Clinical trials
Pathologic Processes trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 5 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Bordeaux | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Zealand Pharma | 2 |
| Aeris Therapeutics | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| AusperBio Therapeutics Inc. | 1 |
| BBB-Therapeutics B.V. | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 19 |
| Lung Diseases | 6 |
| Respiratory Tract Diseases | 6 |
| Digestive System Diseases | 5 |
| Cystic Fibrosis | 3 |
| Fibrosis | 3 |
| Genetic Diseases, Inborn | 3 |
| Immune System Diseases | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.